Literature DB >> 3116096

Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway.

L E Lambert1, D M Paulnock.   

Abstract

Macrophage activation for tumor cell killing is a multistep pathway in which responsive macrophages interact sequentially with priming and triggering stimuli in the acquisition of full tumoricidal activity. Although this synergistic response of normal macrophages to sequential incubation with activation signals has been well established, characterization of the intermediate stages in this pathway has been difficult, due in large measure to the instability of the intermediate cell phenotypes. We have developed a model system for examination of macrophage-mediated tumor cell lysis, with the use of the murine macrophage tumor cell line RAW 264.7. These cells, like normal macrophages, exhibit a strict requirement for interaction with both interferon-gamma (IFN-gamma, the priming signal) and bacterial lipopolysaccharide (LPS, the triggering signal) in the development of tumor cytolytic activity. In this system, the priming effects of IFN-gamma decay rapidly after withdrawal of this mediator and the cells become unresponsive to LPS triggering. We have recently observed that gamma-irradiation of the RAW 264.7 cells also results in development of a primed activation state for tumor cell killing. The effects of gamma-radiation on the RAW 264.7 cell line are strikingly similar to those resulting from incubation with IFN-gamma, with the exception that the irradiation-induced primed cell intermediate is stable and responsive to LPS triggering for at least 24 hr. Treatment with gamma-radiation also results in increased cell surface expression of major histocompatibility complex-encoded class I antigens; however, class II antigen expression is not induced. Irradiation-induced development of the primed phenotype is not solely the result of cytostatic effects as treatment of the cells with a radiomimetic drug, mitomycin C, results in decreases in [3H]thymidine incorporation that are similar to those observed after irradiation, without concomitant development of cytolytic potential. In addition, priming by gamma-radiation does not appear to be mediated by the release of soluble autoregulatory factors. This alternate pathway for induction of the primed macrophage activation state should serve as a useful tool for identification of molecules important to the functional potential of primed cells, and for elucidation of the biochemical mechanisms of the priming event in tumoricidal activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116096

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11.

Authors:  Amanda Waddell; Richard Ahrens; Kris Steinbrecher; Burke Donovan; Marc E Rothenberg; Ariel Munitz; Simon P Hogan
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

2.  Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing.

Authors:  M Haak-Frendscho; T A Wynn; C J Czuprynski; D Paulnock
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 3.  Immune microenvironments in solid tumors: new targets for therapy.

Authors:  Stephen L Shiao; A Preethi Ganesan; Hope S Rugo; Lisa M Coussens
Journal:  Genes Dev       Date:  2011-12-15       Impact factor: 11.361

4.  Immunomodulatory and cytoprotective role of RP-1 in gamma-irradiated mice.

Authors:  H C Goel; P K Agrawala; V Pathania; N Malhotra
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

5.  Relationship of tumor necrosis factor alpha, the nitric oxide synthase pathway, and lipopolysaccharide to the killing of gamma interferon-treated macrophage-like RAW264.7 cells by Rickettsia prowazekii.

Authors:  J Turco; H H Winkler
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy.

Authors:  Yuru Meng; Michael A Beckett; Hua Liang; Helena J Mauceri; Nico van Rooijen; Kenneth S Cohen; Ralph R Weichselbaum
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

Review 7.  The tumor-immune microenvironment and response to radiation therapy.

Authors:  Stephen L Shiao; Lisa M Coussens
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-16       Impact factor: 2.673

Review 8.  The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy.

Authors:  Katrien De Wolf; Karim Vermaelen; Gert De Meerleer; Bart N Lambrecht; Piet Ost
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

9.  Radiation-induced effects and the immune system in cancer.

Authors:  Punit Kaur; Alexzander Asea
Journal:  Front Oncol       Date:  2012-12-17       Impact factor: 6.244

10.  Proteome of monocyte priming by lipopolysaccharide, including changes in interleukin-1beta and leukocyte elastase inhibitor.

Authors:  Michael J Pabst; Karen M Pabst; David B Handsman; Sarka Beranova-Giorgianni; Francesco Giorgianni
Journal:  Proteome Sci       Date:  2008-05-20       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.